Cargando…
Production in Bacteria and Characterization of Engineered Humanized Fab Fragment against the Nodal Protein
Drug development in recent years is increasingly focused on developing personalized treatments based on blocking molecules selective for therapeutic targets specifically present in individual patients. In this perspective, the specificity of therapeutic targets and blocking agents plays a crucial ro...
Autores principales: | Sivaccumar, Jwala P., Iaccarino, Emanuela, Oliver, Angela, Cantile, Maria, Olimpieri, Pierpaolo, Leonardi, Antonio, Ruvo, Menotti, Sandomenico, Annamaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459755/ https://www.ncbi.nlm.nih.gov/pubmed/37631045 http://dx.doi.org/10.3390/ph16081130 |
Ejemplares similares
-
Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments
por: Sandomenico, Annamaria, et al.
Publicado: (2020) -
Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry
por: Sivaccumar, Jwala Priyadarsini, et al.
Publicado: (2021) -
New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding
por: Focà, Annalia, et al.
Publicado: (2015) -
Unveiling CD59-Antibody Interactions to Design Paratope-Mimicking Peptides for Complement Modulation
por: Sandomenico, Annamaria, et al.
Publicado: (2023) -
Members of the GADD45 Protein Family Show Distinct Propensities to form Toxic Amyloid-Like Aggregates in Physiological Conditions
por: Smaldone, Giovanni, et al.
Publicado: (2021)